Guidance vs practice: How can we improve treatment of SR-GvHD?
Agenda
Welcome and introductions
- Introduction to the GvHD Hub
- Satellite symposium educational objectives and pre-activity test
- Introduction to the speakers
Early treatment strategies for SR-GvHD
- A review of current therapeutic strategies for SR-GvHD and treatment guidelines
- The importance of early detection of GvHD, including inflammation and fibrosis
- How early treatment of SR-GvHD is approached in clinical practice, and how this may vary from guidelines
- The impact of early treatment switching and escalation on long-term outcomes
The importance of real-world data
- An overview of current real-world data and ongoing studies in SR-GvHD (including efficacy and safety findings)
- How real-world evidence can supplement guidelines to inform treatment decisions
- Case-based discussion: Interactive discussion, using case studies, focusing on treatment selection
Quality of life in GvHD
- An overview of QoL assessment tools and the current utilization of these in clinical practice vs clinical trials
- Panel discussion: How to incorporate QoL into GvHD treatment sequencing to ensure optimal outcomes for patients
Learning objectives
After attending this webinar, learners will be able to:
- Describe novel therapeutic targets in GvHD and explain the mechanisms of action for new agents.
- Recall the latest data for new agents in development for GvHD and describe the rationale for selecting such treatments based on treatment- and patient-related factors.
- Explain how quality of life can be impacted in patients with GvHD and how this can be better managed in clinical practice.
Our speakers
Meet our panel of experts
Mohamad Mohty
Hôpital Saint-Antoine and Sorbonne University
Paris, FR
Daniel Wolff
University Hospital Regensburg
Regensburg, DE
Steven Pavletic
National Cancer Institute
Bethesda, US
About SES
Delivering streamlined independent medical education to enhance clinical practice. SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide with up-to-date, accessible, and impactful educational content.
About the GvHD Hub
The GvHD Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in GvHD. Our aim is to enhance knowledge in GvHD through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.
The GvHD Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage with treatment teams and researchers around the world.